Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
Study Information
Alliance Study ID: NCCTG-N004E
NCT Study ID (ClinicalTrials.gov): NCT00066781
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Matthew P. Goetz, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy such as gemcitabine and irinotecan use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with irinotecan works in treating patients with cancer of unknown primary origin.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information